Skip to main content

Advertisement

Table 1 Patient characteristics

From: Renal protective effect of a hydration supplemented with magnesium in patients receiving cisplatin for head and neck cancer

Characteristics All (n = 121) Crystalloid -only regimen (n = 65) Magnesium –supplemented regimen (n = 56) P value
Age Median (range) 62 (28–78) 62 (28–77) 62 (42–78) 0.2943
Sex Male 102 52 50 0.1616*
Female 19 13 6
BSA (m2) Median (range) 1.63 (1.27–2.00) 1.59 (1.33–1.96) 1.65 (1.27–2.00) 0.2542
PS 0 / 1 / 2 67 / 46 / 8 38 / 22 / 5 29 / 24 / 3 0.5676*
Primary Site Nasal cavity and Paranasal sinuses 15 14 1 0.0001*
Oral cavity 4 4 0
Nasopharynx 1 0 1
Oropharynx 40 15 25
Hypopharynx 32 18 14
Laryynx 8 1 7
Cervical esophagus 13 7 6
Unknown 8 6 2
Creatine (mg/dL) Median (range) 0.71 (0.38–1.07) 0.69 (0.38–1.07) 0.73 (0.51–1.07) 0.1152
Ccr (m L/min) Median (range) 89.1 (54.5–186.7) 79.1 (54.5–156.1) 89.1 (57.0–143.6) 0.1712
Albumin (g/mL) Median (range) 4.1 (2.9–5.1) 4.1 (3.0–5.0) 4.2 (2.9–5.1) 0.1081
Hematocrit (%) Median (range) 39.7 (26.6–50.8) 39.1 (26.6–50.8) 40.4 (31.3–48.6) 0.1001
Aprepitant Administration 78 22 56 < 0.0001
  1. BSA body surface area, Ccr creatinine clearance
  2. *Fisher’s exact test; Student’s t-test